# VeraFlo With Prontosan® and Wound and Fracture Healing.

> **NCT02621073** · NA · TERMINATED · sponsor: **Brett Crist** · enrollment: 7 (actual)

## Conditions studied

- Infection

## Interventions

- **DRUG:** VeraFlo with Prontosan
- **DEVICE:** V.A.C Ulta System

## Key facts

- **NCT ID:** NCT02621073
- **Lead sponsor:** Brett Crist
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-11
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Enrollment was more difficult than expected. It was mutually agreed upon that we would close the study. No results to report.
- **Last updated:** 2019-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02621073

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02621073, "VeraFlo With Prontosan® and Wound and Fracture Healing.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02621073. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*